Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 00:17:06 - browse：4582

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Morgan Health, with ambitious aims, wants you to know it’s still here

entertainment

WSS

Antibiotic resistance and the global rise in human conflict

UCB departs biotech trade group BIO

Europe is fastest

U.K. sequencing study surfaces new findings about tumor DNA

White House finalizes ITC's import ban of latest Apple Watches

HCA says smaller share of spending going to labor

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

At least 13 dead in Texas as scorching temps continue

Videos point to link between seizures and unexplained toddler deaths

The high cost of giving birth even with insurance

Burning questions for the 2024 JPM Healthcare Conference

Peter Hotez and the public health issue of online harassment

Burning questions for the 2024 JPM Healthcare Conference

Moonlake's readout produced a cash windfall. Risks remain

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Apple is now the first public company to be valued at $3 trillion

Burning questions for the 2024 JPM Healthcare Conference

leisure time

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

Feng Zhang CRISPR delivery startup lays off quarter of staff

Doctors increasingly discourage vaping amid mounting health concerns

Federal weight loss drug coverage is 30 years out of date

White House finalizes ITC's import ban of latest Apple Watches

3 medical device trends to watch in 2024

focus

explore

entertainment

leisure time